Quantcast
Environmental News for a Healthier Planet and Life

When Will There Be a Coronavirus Vaccine? 5 Questions Answered

Health + Wellness
When Will There Be a Coronavirus Vaccine? 5 Questions Answered
The Director of the Chinese Center for Disease Control and Prevention, Gao Fu speaks on Jan. 26 during a press briefing on studying the 2019-nCoV coronavirus and developing a vaccine to prevent it. Roman Balandin / TASS / Getty Images

Editor's note: The coronavirus that started in Wuhan has sickened more than 4,000 people and killed at least 100 in China as of Jan. 27, 2020. Thailand and Hong Kong each have reported eight confirmed cases, and five people in the U.S. have been diagnosed with the illness. People are hoping for a vaccine to slow the spread of the disease.


Is there a vaccine under development for the coronavirus?

Work has begun at multiple organizations, including the National Institutes of Health, to develop a vaccine for this new strain of coronavirus, known among scientists as 2019-nCoV.

Scientists are just getting started working, but their vaccine development strategy will benefit both from work that has been done on closely related viruses, such as SARS and MERS, as well as advances that have been made in vaccine technologies, such as nucleic acid vaccines, which are DNA- and RNA-based vaccines that produce the vaccine antigen in your own body.

Was work underway on this particular strain?

No, but work was ongoing for other closely related coronaviruses that have caused severe disease in humans, namely MERS and SARS. Scientists had not been concerned about this particular strain, as we did not know that it existed and could cause disease in humans until it started causing this outbreak.

How do scientists know when to work on a vaccine for a coronavirus?

Work on vaccines for severe coronaviruses has historically begun once the viruses start infecting humans.

Given that this is the third major outbreak of a new coronavirus that we have had in the past two decades and also given the severity of disease caused by these viruses, we should consider investing in the development of a vaccine that would be broadly protective against these viruses.

What does this work involve, and when might we actually have a vaccine?

This work involves designing the vaccine constructs – for example, producing the right target antigens, viral proteins that are targeted by the immune system, followed by testing in animal models to show that they are protective and safe.

Once safety and efficacy are established, vaccines can advance into clinical trials in humans. If the vaccines induce the expected immune response and protection and are found safe, they can be mass produced for vaccination of the population.

Currently, we lack virus isolates – or samples of the virus – to test the vaccines against. We also lack antibodies to make sure the vaccine is in good shape. We need the virus in order to test if the immune response induced by the vaccine works. Also, we need to establish what animals to test the vaccine on. That potentially could include mice and nonhuman primates.

Vaccine development will likely take months.

Can humans ever be safe from these types of outbreaks?

We expect that these types of outbreaks will occur for the foreseeable future in irregular intervals.

To try to prevent large outbreaks and pandemics, we need to improve surveillance in both humans and animals worldwide as well as invest in risk assessment, allowing scientists to evaluate the potential threat to human health from the virus, for detected viruses.

We believe that global action is needed to invest in novel vaccine approaches that can be employed quickly whenever a new virus like the current coronavirus – and also viruses similar to Zika, Ebola or influenza – emerges. Currently, responses to emerging pathogens are mostly reactive, meaning they start after the outbreak happens. We need a more proactive approach supported by continuous funding.

Reposted with permission from The Conversation.

Florida Wildlife Federation / NBC2News / YouTube

In a dramatic rescue captured on camera, a Florida man ran into a pond and pried open an alligator's mouth in order to rescue his beloved puppy, all without dropping his cigar.

Read More Show Less

EcoWatch Daily Newsletter

Imagesines / iStock / Getty Images Plus

Jean-Marc Neveu and Olivier Civil never expected to find themselves battling against disposable mask pollution.

When they founded their recycling start-up Plaxtil in 2017, it was textile waste they set their sights on. The project developed a process that turned fabrics into a new recyclable material they describe as "ecological plastic."

Read More Show Less

Trending

Fossil fuel companies received $110 billion in direct and indirect financial assistance during the coronavirus pandemic, including up to $15.2 billion in direct federal relief. Andrew Hart /

By Bret Wilkins

In a year in which the United States has already suffered 16 climate-driven extreme weather events causing more than $1 billion in economic damages, and as millions of American workers face loss of essential unemployment benefits due to congressional inaction, a report published Monday reveals the Trump administration has given fossil fuel companies as much as $15.2 billion in direct relief — and tens of billions more indirectly — through federal COVID-19 recovery programs since March.

Read More Show Less
Flint corn is an example of pre-contact food. Elenathewise / Getty Images

By Ashia Aubourg

As Thanksgiving approaches, some Indigenous organizations and activists caution against perpetuating further injustices towards Native communities. Indigenous activist Mariah Gladstone, for example, encourages eaters to celebrate the harvest time in ways that do not involve stereotypes and pilgrim stories.

Read More Show Less

By Alex Middleton

Losing weight and reducing fat is a hard battle to fight. Thankfully, there are fat burner supplements that help you gain your target body and goal. However, how would you know which supplement is right for you?

Read More Show Less